The Next Generation Molecular Test For Prostate Cancer

Trademark details

The Next Generation Molecular Test For Prostate Cancer® is a registered trademark used for Healthcare and Medical Services, Namely, Medical Pathology Services For the Diagnosis and Treatment of Diseases and owned by Bostwick Laboratories, Inc.. Full trade mark registration details, registered images and more information below.

View more »

the next generation molecular test for prostate cancer
Goods and/or Services:

Healthcare and Medical Services, Namely, Medical Pathology Services For the Diagnosis and Treatment of Diseases

Serial Number: 78935987
Registration Number: 3290966
Filing Date: Jul 24, 2006
Last Applicant(s)/
Owner(s) of Record

Bostwick Laboratories, Inc.

4355 Innslake Drive
Glen Allen, Va 23060 US

Related Products:
Medical services; Veterinary services; Hygienic and beauty care for humans or animals

Suppliers

Total : 1   View more »

Bostwick Laboratories Inc in Lake Jackson, Texas, USA

Edit this Company edit this company Bostwick Laboratories Inc 188 Abner Jackson Pkwy Lake Jackson, Texas 77566-5160 USA tel: +1 9792974841 Description Testing Laboratory Location Products Testing Laboratories

Web Sites powered by Bing

Total : 17,100,000   View more »

THE NEXT GENERATION MOLECULAR TEST FOR PROSTATE CANCER Trademark ...

Trademark details. The Next Generation Molecular Test For Prostate Cancer® is a registered trademark used for Healthcare and Medical Services, Namely, Medical ...

The Future of Cancer Diagnostics: Next Generation Molecular ...

The Future of Cancer Diagnostics: Next Generation Molecular ... Tissue-based Predictive Tests in Prostate Cancer ... 00 Genomic Analysis of Cancer with Next Generation ...

The Future of Cancer Diagnostics: Next Generation Molecular ...

The Future of Cancer Diagnostics: Next Generation Molecular ... New molecular tests such as breast cancer prognosis are ... the serum of men with prostate cancer ...

PCA3Plus(TM) the Next Generation Genetic Test for Prostate Cancer ...

PCA3Plus(TM) the Next Generation Genetic Test for Prostate Cancer Risk: Exclusively From Bostwick Laboratories, Inc.

 
 

Explore Related Topics: